Skip to main content
NVDA-2.58%AAPL+3.15%GOOGL+0.50%MSFT-0.13%AMZN-0.26%TSM-1.46%SPCX+0.70%AVGO-0.67%META-1.29%TSLA-0.60%SKHY-4.39%MU-4.61%BRK-B-0.24%LLY+0.04%JPM-0.72%WMT-0.10%AMD-3.24%V-0.17%XOM+0.85%ASMLa-1.66%JNJ-0.04%INTC-4.93%MA-0.53%0700.HK-1.94%1398.HK+0.79%ORCL-4.28%ABBV+1.09%BAC-0.57%CSCO-1.08%CVX-0.28%COST-0.14%KO+0.67%LRCX-5.12%CAT-1.58%AP2d-1.55%0005.HK-0.78%AMAT-2.74%UNH-0.99%HSBA.L-1.30%DELL-3.27%PG+0.48%MS-1.16%GE-0.76%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.19%HD-1.90%0939.HK+1.66%GS-1.28%NZDJPY-2.64%AUDJPY-1.85%CHFJPY-1.61%NZDCAD-1.47%EURNZD+1.44%NZDUSD-1.43%GBPNZD+1.39%GBPJPY-1.26%EURJPY-1.24%USDJPY-1.24%CADJPY-1.18%NZDCHF-1.07%USDZAR+1.02%USDNOK+0.90%USDSEK+0.90%EURZAR+0.84%AUDNZD+0.81%GBPZAR+0.76%EURNOK+0.72%EURSEK+0.71%AUDCAD-0.70%USDTHB+0.67%AUDDKK-0.65%AUDUSD-0.62%EURAUD+0.62%GBPAUD+0.58%CHFNOK+0.56%CHFSEK+0.56%AUDSGD-0.55%USDMXN+0.53%USDPLN+0.45%NZDSGD-0.43%GBPTRY+0.41%CADCHF+0.41%NOKJPY-0.39%USDCHF+0.39%EURCHF+0.37%GBPCHF+0.34%GBPHKD+0.32%GBPMXN-0.28%USDSGD+0.28%EURPLN+0.26%AUDCHF-0.24%SGDJPY+0.23%NZDMXN-0.20%EURHKD-0.19%USDDKK+0.18%USDILS+0.16%USDTRY+0.11%USDCNH+0.10%EURSGD+0.09%GBPCAD-0.09%AUDNOK+0.07%EURCNH-0.06%EURCAD-0.06%CHFSGD-0.06%PLNJPY+0.06%EURCZK-0.05%USDCOP-0.04%EURGBP+0.04%USDCAD-0.04%GBPUSD-0.03%USDHKD+0.02%EURUSD-0.01%GBPSGD+0.01%EURDKK0.00%XPTUSD-6.16%GAGUSD-5.41%XAGUSD-5.41%UKOIL+5.19%USOIL+5.04%HG1-4.88%XAUUSD-1.85%GAUUSD-1.85%XNGUSD+1.63%SUGAR0.00%S10.00%COFFEE0.00%BTCUSD-1.43%ETHUSD-0.13%USDTUSD-0.02%XRPUSD-3.04%SOLUSD-1.72%TRXUSDT+0.18%ZECUSDT-9.00%DOGEUSD-2.63%XMRUSDT+0.93%LINKUSD-1.35%XLMUSD-1.44%BCHUSDT-9.83%LTCUSD-1.66%UNIUSD-1.56%TONUSD+24.88%HBARUSDT-2.45%SUIUSD-4.15%TAOUSDT-5.36%AAVEUSD-2.39%DOTUSDT-1.74%ICPUSDT-0.94%ONDOUSDT-3.15%WLDUSDT-2.91%ATOMUSDT-2.92%ARBUSDT-0.91%JUPUSDT-3.39%INJUSDT-2.24%STXUSDT-4.53%FETUSDT-2.86%TIAUSDT-0.87%PYTHUSDT-1.42%SEIUSDT-6.02%IMXUSDT-3.85%GRTUSDT-3.45%WIFUSDT-5.38%OPUSDT-3.00%POLUSDT-4.46%IOTAUSDT-3.74%AXSUSDT-2.47%FARTCOINUSDT-2.90%EOSUSDT-2.66%DYDXUSDT-1.99%ORDIUSDT-0.80%GALAUSDT-3.09%NOTUSDT-2.97%RONINUSDT-2.64%NVDA-2.58%AAPL+3.15%GOOGL+0.50%MSFT-0.13%AMZN-0.26%TSM-1.46%SPCX+0.70%AVGO-0.67%META-1.29%TSLA-0.60%SKHY-4.39%MU-4.61%BRK-B-0.24%LLY+0.04%JPM-0.72%WMT-0.10%AMD-3.24%V-0.17%XOM+0.85%ASMLa-1.66%JNJ-0.04%INTC-4.93%MA-0.53%0700.HK-1.94%1398.HK+0.79%ORCL-4.28%ABBV+1.09%BAC-0.57%CSCO-1.08%CVX-0.28%COST-0.14%KO+0.67%LRCX-5.12%CAT-1.58%AP2d-1.55%0005.HK-0.78%AMAT-2.74%UNH-0.99%HSBA.L-1.30%DELL-3.27%PG+0.48%MS-1.16%GE-0.76%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.19%HD-1.90%0939.HK+1.66%GS-1.28%NZDJPY-2.64%AUDJPY-1.85%CHFJPY-1.61%NZDCAD-1.47%EURNZD+1.44%NZDUSD-1.43%GBPNZD+1.39%GBPJPY-1.26%EURJPY-1.24%USDJPY-1.24%CADJPY-1.18%NZDCHF-1.07%USDZAR+1.02%USDNOK+0.90%USDSEK+0.90%EURZAR+0.84%AUDNZD+0.81%GBPZAR+0.76%EURNOK+0.72%EURSEK+0.71%AUDCAD-0.70%USDTHB+0.67%AUDDKK-0.65%AUDUSD-0.62%EURAUD+0.62%GBPAUD+0.58%CHFNOK+0.56%CHFSEK+0.56%AUDSGD-0.55%USDMXN+0.53%USDPLN+0.45%NZDSGD-0.43%GBPTRY+0.41%CADCHF+0.41%NOKJPY-0.39%USDCHF+0.39%EURCHF+0.37%GBPCHF+0.34%GBPHKD+0.32%GBPMXN-0.28%USDSGD+0.28%EURPLN+0.26%AUDCHF-0.24%SGDJPY+0.23%NZDMXN-0.20%EURHKD-0.19%USDDKK+0.18%USDILS+0.16%USDTRY+0.11%USDCNH+0.10%EURSGD+0.09%GBPCAD-0.09%AUDNOK+0.07%EURCNH-0.06%EURCAD-0.06%CHFSGD-0.06%PLNJPY+0.06%EURCZK-0.05%USDCOP-0.04%EURGBP+0.04%USDCAD-0.04%GBPUSD-0.03%USDHKD+0.02%EURUSD-0.01%GBPSGD+0.01%EURDKK0.00%XPTUSD-6.16%GAGUSD-5.41%XAGUSD-5.41%UKOIL+5.19%USOIL+5.04%HG1-4.88%XAUUSD-1.85%GAUUSD-1.85%XNGUSD+1.63%SUGAR0.00%S10.00%COFFEE0.00%BTCUSD-1.43%ETHUSD-0.13%USDTUSD-0.02%XRPUSD-3.04%SOLUSD-1.72%TRXUSDT+0.18%ZECUSDT-9.00%DOGEUSD-2.63%XMRUSDT+0.93%LINKUSD-1.35%XLMUSD-1.44%BCHUSDT-9.83%LTCUSD-1.66%UNIUSD-1.56%TONUSD+24.88%HBARUSDT-2.45%SUIUSD-4.15%TAOUSDT-5.36%AAVEUSD-2.39%DOTUSDT-1.74%ICPUSDT-0.94%ONDOUSDT-3.15%WLDUSDT-2.91%ATOMUSDT-2.92%ARBUSDT-0.91%JUPUSDT-3.39%INJUSDT-2.24%STXUSDT-4.53%FETUSDT-2.86%TIAUSDT-0.87%PYTHUSDT-1.42%SEIUSDT-6.02%IMXUSDT-3.85%GRTUSDT-3.45%WIFUSDT-5.38%OPUSDT-3.00%POLUSDT-4.46%IOTAUSDT-3.74%AXSUSDT-2.47%FARTCOINUSDT-2.90%EOSUSDT-2.66%DYDXUSDT-1.99%ORDIUSDT-0.80%GALAUSDT-3.09%NOTUSDT-2.97%RONINUSDT-2.64%
VE

Verastem, Inc. (VSTM)

NASDAQ • Healthcare

$7.94
-$0.13 (-1.7%)
Market open

Last close at September 9, 2026 at 20:00 UTC

Open$8.01
Previous Close$7.94
Day Range$7.8 - $8.38
Avg. Volume (3M)2.1M
Market Cap$662.5M
52 Week Range
$3.43$10.82
Next EarningsIn 54 daysNov 3, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$40M100%
Gross Profitminus cost of goods$36M90%

In plain terms: out of every $100 in revenue, Verastem, Inc. currently loses $87.

Fundamentals & Financials

Revenue (TTM)
$87.5M
Net Income (TTM)
-$202.6M
EPS (TTM)
-$2.46
ROA (TTM)
-98.15%
Current Ratio
2.25

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+20.4%Q1 2026-$0.39
+19.6%Q2 2026-$0.37
+18.7%Q3 2026-$0.35
Next

Nov 3

in 54 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

View full earnings history

About Verastem, Inc.

Verastem, Inc. is a NASDAQ-listed biotechnology company developing targeted cancer medicines, centered on the clinical candidates VS-6766 and defactinib. The company generated $30.9 million of revenue in FY2025 and operates in the biopharmaceutical research and development business rather than commercial-scale drug manufacturing.

Name
Verastem, Inc.
CEO
Daniel W. Paterson
Website
www.verastem.com
Industry
Healthcare
Year Founded
2010
Employees
102

Today's Snapshot

AI-generated

VSTM is trading 4.8% below yesterday's close, while its sector was flat. Verastem scheduled October data on its G12D cancer drug ahead of planned late-stage trials.

Trading Volume

Below 10d avg (2.4M)

1.1M

vs S&P 500 Today

Strong Underperformance

-4.24%

Updated: September 10, 2026 at 16:36 UTC

Technical Indicators

4 Buy3 Neutral1 Sell
VSTM carries a buy bias driven by a clear trend signal and supportive medium- and long-term moving averages, with the stock trading above the 20- and 200-day averages even as it sits just under the 10-day. ADX is strong, indicating a well-established move, while momentum indicators are neutral-to-positive and MACD is slightly constructive. Volatility is elevated relative to price, and intraday VWAP sits above the market which tempers the view; volume readings are mixed. Technical takeaway: Buy.
All signals
  • EMA (5 indicators)$6.16 - $7.70
    Buy
  • RSI (14)57.27
    Neutral
  • Stochastic %K (14, 3, 3)64.40
    Neutral
  • MACD Level (12, 26)0.45
    Neutral

Peers & Related Assets

ABSIAbsci Corporation
$8.65-2.9%
CRVSCorvus Pharmaceuticals, Inc.
$13.33-4.3%
OLMAOlema Pharmaceuticals, Inc.
$10.36-5.7%
FDMT4D Molecular Therapeutics, Inc.
$14.18-3.1%
PRTAProthena Corporation plc
$9.3-2.5%
RGNXREGENXBIO Inc.
$8.73-0.3%
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.